Weil, Wachtell, Shearman, Simpson, Latham and Davis Polk all got the year's second quarter off to a strong start by grabbing roles on one of two big pharmaceutical deals announced Monday: Irish specialty drugmaker Mallinckrodt's $5.6 billion cash-and-stock purchase of California's Questcor Pharmaceuticals and India's Sun Pharmaceutical Industries' $3.2 billion buy of struggling rival Ranbaxy Laboratories.
April 07, 2014 at 07:41 PM
1 minute read
UPDATE: 4/9/14, 8:30 a.m. EDT. Information on Irish counsel for Questcor has been added to the second paragraph of this story.
A half-dozen Am Law 100 firms—many of them home to lawyers featured in The American Lawyer’s latest Corporate Scorecard and Dealmaker of the Year report—got the second quarter of 2014 off to a strong start by grabbing roles on two big M&A transactions announced Monday in the pharmaceutical sector.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.
